Company / Depreciation & Amortization
AXIM BIOTECHNOLOGIES, INC. Depreciation & Amortization History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$427.0K
FY2023
5-year range
$3.4K / $427.0K
FY2019-FY2023
Trend
+0.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $1,119 in FY2015 to $427,019 in FY2023.
Based on SEC 10-K filings.
$427,019 in FY2023.
Increased from $3,356 to $427,019 over the past 7 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, depreciation & amortization increased 0.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $427.0K | +0.2% |
| FY2022 | $426.1K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $3.4K | +199.9% |
| FY2015 | $1.1K | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026